| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 271,766 | 274,736 | 247,248 | 279,308 | | Cost of Revenue | (199,735) | 99,414 | 100,321 | 107,987 | | | Gross Profit | 471,501 | 175,322 | 146,927 | 171,321 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 352,625 | 59,058 | 57,203 | 56,859 | | Non Recurring |
-
| (1,221) | (652) | (3,483) | | Others | 83,529 | 83,489 | 85,774 | 94,172 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,569 | 33,996 | 4,602 | 23,773 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,315) | 3,708 | 145 | 205 | | Earnings Before Interest And Taxes | 40,273 | 37,704 | 4,747 | 23,978 | | Interest Expense | 52,090 | 56,645 | 36,350 | 39,605 | | Income Before Tax | (11,817) | (18,941) | (31,603) | (15,627) | | Income Tax Expense | 41,397 | (7,122) | (10,270) | (8,790) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (56,884) | (11,819) | (21,333) | (6,837) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,204) | (11,819) | (21,333) | (6,837) | | Preferred Stock And Other Adjustments | (91) | (91) | (91) | (92) | | | Net Income Applicable To Common Shares | ($5,295) | ($11,910) | ($21,424) | ($6,929) |
|
0.83% Nasdaq 0.00%
Income Statement
